Ring chromosomes in dermatofibrosarcoma protuberans are composed of interspersed sequences from chromosomes 17 and 22 - PubMed

Affiliations

• PMID: 7495279
• PMCID: PMC1869963

Ring chromosomes in dermatofibrosarcoma protuberans are composed of interspersed sequences from chromosomes 17 and 22

R Naeem et al. Am J Pathol. 1995 Dec.

Abstract

Ring chromosomes are found in most dermatofibrosarcoma protuberans (DFSPs), and recent reports demonstrate that portions of the DFSP ring chromosomes derive from chromosome 17. In this study we characterized ring chromosomes in three DFSPs using a combined approach of karyotyping, chromosome painting, and comparative genomic hybridization. Chromosome painting demonstrated that the ring chromosomes in each DFSP were composed of discontinuous, interwoven sequences from chromosomes 17 and 22. Amplification of chromosomes 17 and 22 sequences was confirmed in each of these cases by comparative genomic hybridization, and over-representation of chromosomes 17 and 22 sequences was also demonstrated by comparative genomic hybridization in 1 of 2 cytogenetically unremarkable DFSPs. We conclude that amplification of chromosomes 17 and 22 sequences, in ring form, is a characteristic aberration in DFSP.

Similar articles

• Supernumerary ring chromosomes in dermatofibrosarcoma protuberans may contain sequences from 8q11.2-qter and 17q21-qter: a combined cytogenetic and comparative genomic hybridization study.

  Nishio J, Iwasaki H, Ohjimi Y, Ishiguro M, Isayama T, Naito M, Kaneko Y, Kikuchi M. Nishio J, et al. Cancer Genet Cytogenet. 2001 Sep;129(2):102-6. doi: 10.1016/s0165-4608(01)00447-2. Cancer Genet Cytogenet. 2001. PMID: 11566338

• Spectral karyotyping reveals 17;22 fusions in a cytogenetically atypical dermatofibrosarcoma protuberans with a large marker chromosome as a sole abnormality.

  Mrózek K, Iliszko M, Ryś J, Babińska M, Niezabitowski A, Bloomfield CD, Limon J. Mrózek K, et al. Genes Chromosomes Cancer. 2001 Jun;31(2):182-6. doi: 10.1002/gcc.1131. Genes Chromosomes Cancer. 2001. PMID: 11319805

• Involvement of chromosomes 17 and 22 in dermatofibrosarcoma protuberans.

  Minoletti F, Miozzo M, Pedeutour F, Sard L, Pilotti S, Azzarelli A, Turc-Carel C, Pierotti MA, Sozzi G. Minoletti F, et al. Genes Chromosomes Cancer. 1995 May;13(1):62-5. doi: 10.1002/gcc.2870130110. Genes Chromosomes Cancer. 1995. PMID: 7541645 Review.

• [Molecular genetics of dermatofibrosarcoma protuberans: an update].

  Zhou XL, Fan QH. Zhou XL, et al. Zhonghua Bing Li Xue Za Zhi. 2006 Jan;35(1):44-7. Zhonghua Bing Li Xue Za Zhi. 2006. PMID: 16608650 Review. Chinese. No abstract available.

Cited by

• Dermatofibrosarcoma protuberans (DFSP): predictors of recurrence and the use of systemic therapy.

  Fields RC, Hameed M, Qin LX, Moraco N, Jia X, Maki RG, Singer S, Brennan MF. Fields RC, et al. Ann Surg Oncol. 2011 Feb;18(2):328-36. doi: 10.1245/s10434-010-1316-5. Epub 2010 Sep 16. Ann Surg Oncol. 2011. PMID: 20844969 Free PMC article. Clinical Trial.

• Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor.

  Antonescu CR, Zhang L, Nielsen GP, Rosenberg AE, Dal Cin P, Fletcher CD. Antonescu CR, et al. Genes Chromosomes Cancer. 2011 Oct;50(10):757-64. doi: 10.1002/gcc.20897. Epub 2011 Jun 29. Genes Chromosomes Cancer. 2011. PMID: 21717526 Free PMC article.

• Targeted therapy for dermatofibrosarcoma protuberans.

  Abrams TA, Schuetze SM. Abrams TA, et al. Curr Oncol Rep. 2006 Jul;8(4):291-6. doi: 10.1007/s11912-006-0035-3. Curr Oncol Rep. 2006. PMID: 17254529 Review.

• Usefulness of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in dermatofibrosarcoma protuberans on treatment with imatinib.

  Kashyap R, Muddu VK, Anantamakula S, Sri S. Kashyap R, et al. Indian J Nucl Med. 2016 Jul-Sep;31(3):191-3. doi: 10.4103/0972-3919.181528. Indian J Nucl Med. 2016. PMID: 27385888 Free PMC article.

• Imatinib in the treatment of solid tumours.

  Duffaud F, Le Cesne A. Duffaud F, et al. Target Oncol. 2009 Jan;4(1):45-56. doi: 10.1007/s11523-008-0101-x. Epub 2009 Jan 27. Target Oncol. 2009. PMID: 19343301 Review.

References

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central

• Medical

  • MedlinePlus Health Information